You are here
Desert Hope Treatment Center Opens Recovery Campus
LAS VEGAS, July 29, 2019 /PRNewswire/ -- Desert Hope Treatment Center, a leading provider of substance use treatment services, is providing the recovery community with a new place to turn for ongoing support and resources. Starting August 1, Desert Hope's Rainbow Campus, located at 2975 S. Rainbow Blvd., will offer free recovery meetings twice a week - Wednesdays at 6 p.m. and Sundays at 8 a.m.
"We know that recovery from drug and alcohol addiction is a lifelong journey, and community support is a critical component to maintaining sobriety and avoiding a relapse," said Ambrozino Storr, Desert Hope Treatment Center CEO. "The weekly meetings are just the beginning of what we have planned for the campus."
A recovery bookstore and boutique are also slated to open in the coming weeks, offering an array of items, including 12-step literature, books, sobriety coins and recovery inspired clothing and jewelry. The campus will also serve as a meeting site for Desert Hope alumni who have completed treatment and want to stay engaged with their peers and participate in group activities.
An estimated 22 million Americans are in recovery, making up about 7% of the population.
"Our Rainbow Campus will serve as a safe place for those who have battled this disease and are on the path to a better life," said Storr.
For more information about offerings at Desert Hope's Rainbow Campus, contact Alumni Manager Dee Wirth, at 702-556-7259 or firstname.lastname@example.org.
About Desert Hope Treatment Center
Desert Hope Treatment Center is a part of the American Addiction Centers (NYSE: AAC) family of treatment centers. AAC is a leading provider of inpatient and outpatient substance abuse treatment services. We treat patients who are struggling with drug addiction, alcohol addiction and co-occurring mental/behavioral health issues. We currently operate substance abuse treatment facilities located throughout the United States. These facilities are focused on delivering effective clinical care and treatment solutions. For more information, please find us at www.DesertHopeTreatment.com or follow us on Twitter.
Forward Looking Statements
This release contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are made only as of the date of this release. In some cases, you can identify forward-looking statements by terms such as "anticipates," "believes," "could," "estimates," "expects," "may," "potential," "predicts," "projects," "should," "will," "would," and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these words. Forward-looking statements may include information concerning AAC Holdings, Inc.'s (collectively with its subsidiaries; "AAC Holdings" or the "Company") possible or assumed future results of operations, including descriptions of the Company's revenue, profitability, outlook and overall business strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from the information contained in the forward-looking statements. These risks, uncertainties and other factors include, without limitation: (i) the Company's inability to effectively operate its facilities; (ii) the Company's reliance on its sales and marketing program to continuously attract and enroll clients; (iii) a reduction in reimbursement rates by certain third-party payors for inpatient and outpatient services and point-of-care and definitive lab testing; (iv) the Company's failure to successfully achieve growth through acquisitions and de novo projects; (v) risks associated with estimates of the value of accounts receivable or deterioration in collectability of accounts receivable; (vi) a failure to achieve anticipated financial results from contemplated and prior acquisitions; (vii) the possibility that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of an acquisition; (viii) the Company's failure to achieve anticipated financial results from contemplated and prior acquisitions; (ix) a disruption in the Company's ability to perform diagnostic laboratory services; (x) maintaining compliance with applicable regulatory authorities, licensure and permits to operate the Company's facilities and laboratories; (xi) a disruption in the Company's business and reputational and economic risks associated with the civil securities claims brought by shareholders or claims by various parties; (xii) inability to meet the covenants in the Company's loan documents or lack of borrowing capacity; and (xiii) general economic conditions, as well as other risks discussed in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the year ended December 31, 2018 and other filings with the Securities and Exchange Commission. As a result of these factors, we cannot assure you that the forward-looking statements in this release will prove to be accurate. Investors should not place undue reliance upon forward-looking statements.
SOURCE Desert Hope Treatment Center